Seeking Alpha

Isis Pharmaceuticals (ISIS) forms an alliance with Roche (RHHBY.OB) to utilize Isis' technology...

Isis Pharmaceuticals (ISIS) forms an alliance with Roche (RHHBY.OB) to utilize Isis' technology to develop innovative treatments for Huntington's disease. The companies will look to advance Isis' lead drug candidate which works by blocking the huntingtin protein. Isis will receive an upfront payment of $30M and may reap $362M in milestone payments and licensing fees going forward. 
From other sites
Comments (1)
  • arthurs1
    , contributor
    Comments (358) | Send Message
     
    Excellent validation, Roche was one of the few big pharmas that was not partnered with ISIS. Another validation of the antisense platform.
    8 Apr 2013, 09:45 AM Reply Like
DJIA (DIA) S&P 500 (SPY)
ETF Hub
ETF Screener: Search and filter by asset class, strategy, theme, performance, yield, and much more
ETF Performance: View ETF performance across key asset classes and investing themes
ETF Investing Guide: Learn how to build and manage a well-diversified, low cost ETF portfolio
ETF Selector: An explanation of how to select and use ETFs